CiNTL Pharma today announced the development of an integrated agentic platform designed to reshape how pharmaceutical and biotechnology companies design, manage, and monitor clinical trials across all phases of development.

​

Leiden, The Netherlands, October 16, 2025 — CiNTL Pharma B.V., a data-driven, next-generation contract research organization (CRO), today announced the development of an integrated agentic platform designed to reshape how pharmaceutical and biotechnology companies design, manage, and monitor clinical trials across all phases of development.

​

Born from the shared frustration of data scientists, project management professionals, and clinical trial experts who have spent decades managing global studies, CiNTL Pharma’s innovation addresses one of the industry’s most persistent challenges, disconnected systems and fragmented data.

​

“For too long, systems haven’t talked, insights have been lost, and outsourcing providers rarely listen to the professionals who actually run the work,” said Yolanda Cabrera-Sybesma, CEO, CiNTL Pharma B.V. “The gaps are huge, the systems are fragmented, and innovation often stops where it should start, with data. We know, first hand that it can be done better.”

​

CiNTL Pharma is among the first European CROs to implement agentic intelligence into the core of clinical research operations, built for scalability through advanced data architecture. Its proprietary platform, CiNTL.ai, integrates program design, data management, regulatory compliance, and performance oversight into one intelligent ecosystem; eliminating inefficiencies and enabling smarter, faster, and more compliant execution from preclinical through post-marketing.

​

“AI doesn’t have to be a disruptor,” added Yolanda. “It should be a partner, one that helps accelerate discovery, protect patient confidentiality, ensure compliance, and deliver therapies to those who need them most.”

​

By aligning science, data, and execution through agentic workflows, CiNTL Pharma helps sponsors and life sciences leaders gain full visibility into their operations, reducing waste, improving collaboration, and strengthening regulatory readiness.

​

“The question isn’t what’s difficult,” concluded Yolanda. “It’s why hasn’t anyone fixed this before?”

About CiNTL Pharma B.V.

​

CiNTL Pharma B.V. is a data-driven, agentic contract research organization (CRO) headquartered in Utrecht, The Netherlands. The company provides comprehensive clinical development and outsourcing solutions to the biotechnology, pharmaceutical, and public health sectors. Through its proprietary platform, CiNTL Pharma combines compliance, intelligence, and operational excellence to help clients accelerate innovation and deliver therapies to patients worldwide.

​

Website: www.cintlpharma.com